Literature DB >> 23411880

Association of inflammatory factors with macular edema in branch retinal vein occlusion.

Hidetaka Noma1, Tatsuya Mimura, Shuichiro Eguchi.   

Abstract

OBJECTIVE: To evaluate the association between vitreous fluid levels of inflammatory factors and macular edema in patients with branch retinal vein occlusion (BRVO).
METHODS: In 39 patients with BRVO and macular edema and 21 individuals with idiopathic macular hole (MH) serving as controls, vitreous fluid samples were obtained during vitreoretinal surgery, and the levels of vascular endothelial growth factor (VEGF), soluble VEGF receptor 2 (sVEGFR-2), soluble intercellular adhesion molecule 1 (sICAM-1), interleukin 6 (IL-6), monocyte chemotactic protein 1 (MCP-1), pentraxin 3 (PTX3), and pigment epithelium-derived factor (PEDF) were measured by enzyme-linked immunosorbent assay. Macular edema was examined by optical coherence tomography.
RESULTS: Vitreous fluid levels of sVEGFR-2, VEGF, sICAM-1, IL-6, MCP-1, and PTX3 were significantly higher in the patients with BRVO than in those with MH; however, the PEDF level was significantly lower in the BRVO group. Vitreous fluid levels of all 7 factors were significantly correlated with the retinal thickness at the central fovea. There were also significant correlations of sVEGFR-2 with sICAM-1, IL-6, MCP-1, and PTX3 but no correlation with VEGF. However, there were significant correlations of VEGF with sICAM-1, IL-6, MCP-1, and PEDF in the BRVO group.
CONCLUSIONS: Vitreous fluid levels of sVEGFR-2, VEGF, sICAM-1, IL-6, MCP-1, PTX3, and PEDF are strongly correlated with retinal vascular permeability and the severity of macular edema in patients with BRVO. These findings may be useful for understanding macular edema and developing new treatments for BRVO.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23411880     DOI: 10.1001/2013.jamaophthalmol.228

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  35 in total

1.  Current practice in the management of branch retinal vein occlusion in Japan: Survey results of retina specialists in Japan.

Authors:  Yuichiro Ogura; Mineo Kondo; Kazuaki Kadonosono; Masahiko Shimura; Motohiro Kamei; Akitaka Tsujikawa
Journal:  Jpn J Ophthalmol       Date:  2019-08-19       Impact factor: 2.447

2.  Effect of aflibercept in patients with age-related macular degeneration.

Authors:  Hiroko Okuma; Tatsuya Mimura; Mari Goto; Yuko Kamei; Maiko Yoshida; Aki Kondo; Masao Matsubara
Journal:  Int Ophthalmol       Date:  2015-06-05       Impact factor: 2.031

Review 3.  Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders.

Authors:  Isabel Pascual-Camps; Pablo Hernández-Martínez; Laura Monje-Fernández; Rosa Dolz-Marco; Roberto Gallego-Pinazo; Lihteh Wu; J Fernando Arévalo; Manuel Díaz-Llopis
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-10-15

4.  The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion.

Authors:  Hongfang Yong; Hui Qi; Hongtao Yan; Qianqian Wu; Ling Zuo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-06-01       Impact factor: 3.117

5.  Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy.

Authors:  Misa Suzuki; Norihiro Nagai; Sakiko Minami; Toshihide Kurihara; Mamoru Kamoshita; Hideki Sonobe; Kazuhiro Watanabe; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-15       Impact factor: 3.117

6.  Efficacy of intravitreal conbercept injection on short- and long-term macular edema in branch retinal vein occlusion.

Authors:  Jing-Yi Bai; Wen-Ying Wang; Zhi-Zhi Dou; Bo-Chao Geng; Xiao-Yan Xu; Yuan-Zhang Zhu; Shan-Yao Zhao; Min Liu; Shao-You Jia; Wen-Juan Luo
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

7.  Longitudinal analysis of aqueous humour cytokine expression and OCT-based imaging biomarkers in retinal vein occlusions treated with anti-vascular endothelial growth factor therapy in the IMAGINE study.

Authors:  Sruthi Arepalli; Charles C Wykoff; Joseph R Abraham; Leina Lunasco; Hannah Yu; Ming Hu; Sunil K Srivastava; Jamie L Reese; David Brown; Justis P Ehlers
Journal:  Eye (Lond)       Date:  2022-10-11       Impact factor: 4.456

Review 8.  Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options.

Authors:  Josh O Wallsh; Ron P Gallemore
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

9.  Dye-Free Porcine Model of Experimental Branch Retinal Vein Occlusion: A Suitable Approach for Retinal Proteomics.

Authors:  Lasse Jørgensen Cehofski; Anders Kruse; Benedict Kjærgaard; Allan Stensballe; Bent Honoré; Henrik Vorum
Journal:  J Ophthalmol       Date:  2015-05-03       Impact factor: 1.909

10.  Unilateral macular edema with central retinal vein occlusion in systemic lupus erythematosus: a case report.

Authors:  Hidetaka Noma; Hiroshi Shimizu; Tatsuya Mimura
Journal:  Clin Ophthalmol       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.